Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Cat Allergy Pipeline Review, H2 2016 - 3 Companies & 5 Molecules - Research and Markets

Research and Markets
Posted on: 28 Sep 16

Research and Markets has announced the addition of the "Cat Allergy - Pipeline Review, H2 2016" report to their offering.

Cat Allergy pipeline therapeutics constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. Our latest report Cat Allergy - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Cat Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Cat Allergy Cat allergy is an allergic reaction to one or more allergens produced by cats. Symptoms include sneezing, runny or stuffy nose, facial pain (from nasal congestion), coughing, chest tightness, shortness of breath and wheezing, watery, red or itchy eyes and skin rash or hives. The molecules developed by Companies in Phase II, Preclinical and Discovery stages are 1, 2 and 2 respectively.

Furthermore, this report also reviews of key players involved in therapeutic development for Cat Allergy and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Cat Allergy Overview
  3. Therapeutics Development
  4. Pipeline Products for Cat Allergy - Overview
  5. Pipeline Products for Cat Allergy - Comparative Analysis
  6. Cat Allergy - Therapeutics under Development by Companies
  7. Cat Allergy - Therapeutics under Investigation by Universities/Institutes
  8. Cat Allergy Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Cat Allergy - Products under Development by Companies
  13. Cat Allergy - Products under Investigation by Universities/Institutes
  14. Cat Allergy - Companies Involved in Therapeutics Development
  • ALK-Abello A/S
  • Amgen Inc.
  • Biomay AG

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.